Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety - Wikidata - awgldk - TriplyDB

Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety

Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety

http://www.wikidata.org/entity/Q37249251

about

Cloning the vaccinia virus genome as a bacterial artificial chromosome in Escherichia coli and recovery of infectious virus in mammalian cells Anti-VEGF single-chain antibody GLAF-1 encoded by oncolytic vaccinia virus significantly enhances antitumor therapy Therapeutic cancer vaccines: past, present, and future Synthetic DNA vaccine strategies against persistent viral infections Highly efficient induction of protective immunity by a vaccinia virus vector defective in late gene expression Evidence-Based Biosafety: a Review of the Principles and Effectiveness of Microbiological Containment Measures Subcellular forms and biochemical events triggered in human cells by HCV polyprotein expression from a viral vector Overcoming immunity to a viral vaccine by DNA priming before vector boosting Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin Expression and cellular immunogenicity of a transgenic antigen driven by endogenous poxviral early promoters at their authentic loci in MVA Improved NYVAC-based vaccine vectors GeneChip resequencing of the smallpox virus genome can identify novel strains: a biodefense application.Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes.Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice Generation of recombinant vaccinia viruses via green fluorescent protein selection Potential effect of prior raccoonpox virus infection in raccoons on vaccinia-based rabies immunization.A new permanent cell line derived from the bank vole (Myodes glareolus) as cell culture model for zoonotic viruses.Laboratory worker knowledge, attitudes and practices towards smallpox vaccine.Differential induction of apoptosis, interferon signaling, and phagocytosis in macrophages infected with a panel of attenuated and nonattenuated poxviruses.Role of antibodies in controlling viral disease: lessons from experiments of nature and gene knockouts.Intratumoral delivery of recombinant vaccinia virus encoding for ErbB2/Neu inhibits the growth of salivary gland carcinoma cells Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice Safety and immunogenicity of recombinant poxvirus HIV-1 vaccines in young adults on highly active antiretroviral therapy The diversity of T-cell co-stimulation in the induction of antitumor immunity.Role of genes that modulate host immune responses in the immunogenicity and pathogenicity of vaccinia virus.Horizontal transmissible protection against myxomatosis and rabbit hemorrhagic disease by using a recombinant myxoma virus.Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.Vaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated In vivo without a concomitant reduction in immunogenicity Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model.Vaccinia viruses with a serpin gene deletion and expressing IFN-gamma induce potent immune responses without detectable replication in vivo.Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma Yaba-like disease virus: an alternative replicating poxvirus vector for cancer gene therapy.Vaccinia virus F13L protein with a conserved phospholipase catalytic motif induces colocalization of the B5R envelope glycoprotein in post-Golgi vesicles Cryo-electron tomography of vaccinia virus.Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing Endoplasmic reticulum-Golgi intermediate compartment membranes and vimentin filaments participate in vaccinia virus assembly Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement.Long-term sterilizing immunity to rinderpest in cattle vaccinated with a recombinant vaccinia virus expressing high levels of the fusion and hemagglutinin glycoproteins Autoantigens plus interleukin-10 suppress diabetes autoimmunity.

P2860

Q24535851-E97D6556-343A-4E5E-93E5-A15B5F9366CC Q24655930-39AC695D-1089-4CC9-B9B7-9F44B39B0A5D Q26863283-2F62E0AF-178B-46AF-BCE1-D82BBD21F10D Q27016078-107A460A-BFB5-45C8-9A66-D3C34E204E3F Q27469703-A687909B-9A9F-4412-BDAC-A4F08832BD36 Q27486575-1DF0BED1-D44A-4CE6-8BAB-F792B27E9937 Q27486946-33122CBF-80CA-4288-B58B-2AC8DEC7AF4F Q28217213-FCFDE28E-6D5F-4DDC-8877-CE727FEF7106 Q28476707-48C368EB-F0B8-43A9-8DC9-77A9039A5DD3 Q28727937-DFA4DD22-63F3-4FF0-84B1-093BCBC0BC17 Q28742982-6A7D844E-A958-4D77-B18D-9EEA367FB315 Q30230190-C6154B85-EEBE-4103-B032-6F2E7AD06C9A Q30339052-6B2BB860-BF94-4603-80B5-DB4BDC418EEF Q30425194-A382E67C-02BE-4909-91D4-7A737B069218 Q30857503-98C55F9B-F1DC-4394-8ED2-7D9E9987A832 Q33373833-EF243F3C-4C6D-4DCA-979E-DAA8A000EBD4 Q33453801-FAF72E33-5B84-43A6-8F1C-17269D270839 Q33572180-E15F83E0-B986-4708-8476-A5C1861C80C8 Q33602820-42C31534-EFCC-4CD2-855C-934C8DE172C9 Q33603438-D808AC14-3608-4FAD-BA6A-8410D2822471 Q33645792-08BBFF21-28E4-4767-8918-4D7C01FEA8A1 Q33653229-A00E311F-8746-4629-B2CE-3FBC428C5CA8 Q33696283-F5D07D7F-ABEB-453E-8F6F-E62E056E0E91 Q33754697-91B2C43B-8AF0-4D0A-9E90-471D132ECAE4 Q33776121-321AD712-3C7D-4B99-9253-BF1928C525B1 Q33780579-91EAA2CB-3D85-4680-8761-8E607A32EAD7 Q33792968-96B6317B-8E2E-40E1-A37A-449BD8DFFD99 Q33803714-34AB0971-17BE-45CE-8619-DCFB78D5080C Q33834391-8AC7434B-D356-468C-9BB6-C53326870589 Q33835582-A8688657-1102-4B4D-816E-DBB23D2445F1 Q33838507-AA1715A3-381F-47D9-A18A-1C61B8697F77 Q33840446-901BE2DA-8C41-406A-B3FC-F7B9F16472DB Q33847896-C99D1479-6089-4D9B-B535-97383844DD19 Q33852860-4C0BDC12-9252-43AA-9D90-332281B0E337 Q33864380-98B754A3-31E5-4A56-A5CC-CAEA98E1AD1E Q33953053-3A6ABAFC-FC99-4999-B3FD-1895755511E2 Q33956910-7CD2B973-A143-48A0-90EF-D0CA4D80B348 Q34066011-A409511F-FFCE-465D-9BF9-A8538479C822 Q34106038-BFAB1B97-65B0-47F4-8213-AC6A749AD549 Q34113929-38930A71-DF56-4BAF-81EA-7440308A9A26

P2860

Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety

http://www.wikidata.org/entity/Q37249251

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 1996

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Genetically engineered poxviru ...... ssion, vaccination, and safety

@en

Genetically engineered poxviru ...... sion, vaccination, and safety.

@nl

type

label

Genetically engineered poxviru ...... ssion, vaccination, and safety

@en

Genetically engineered poxviru ...... sion, vaccination, and safety.

@nl

prefLabel

Genetically engineered poxviru ...... ssion, vaccination, and safety

@en

Genetically engineered poxviru ...... sion, vaccination, and safety.

@nl

P1433

Q37249251-8DF6AE14-5837-440B-A72B-011B7AC6AD08

P1476

Q37249251-4647B385-6248-4C3E-B811-DEF5C03379E4

P2093

Q37249251-DAE1D6BB-3971-40B4-9733-408B3F7B8CCB

P2860

Q37249251-02911933-0FA3-4B0F-A013-94C0CFDFDDB4

Q37249251-02A375E5-8B25-4E00-851F-046DA693F64D

Q37249251-0422C638-0826-49AA-AC4D-B8D7E5A63069

Q37249251-045BA429-85FA-464F-9B41-1794B33EC99E

Q37249251-05C3F725-319A-427D-925F-96BFAF312A24

Q37249251-06A806BA-850B-4D22-9B40-3A8527F04495

Q37249251-07434FFD-5301-4260-A589-A2C438B8AFD0

Q37249251-08C8832E-FADD-4783-BBEE-6138369F6396

Q37249251-0955D74A-C485-4EC2-B993-32575B6B8587

Q37249251-09E25C2C-19E2-4AF7-A363-BF09D3ADB23E

P304

Q37249251-4BBDBDBA-FCF2-4C85-9C07-93EF86DE891F

P31

Q37249251-296240F2-8733-4E7B-8F03-A6286FD78496

P356

Q37249251-A96F49B0-62EB-4CBA-8296-B12FBECAC840

P407

Q37249251-8CB73A4C-FAA0-42E8-94E4-5AA9077EB17F

P433

Q37249251-A7CD2A10-8712-4469-8590-8A95EAF81D43

P478

Q37249251-00579A6E-EF49-47DE-8FF8-46E1448F5472

P577

Q37249251-7320E854-F36E-4270-8E30-5F0178BB3AF8

P5875

Q37249251-7C3069BC-3AB7-4E07-AD71-47B2AE35F39F

P698

Q37249251-2C6E9720-EBA0-407E-ABB6-6452265E399C

P932

Q37249251-3B30ED76-2B26-47E9-A217-6BF0DA8E4EF8

P356

PNAS.93.21.11341

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Genetically engineered poxviru ...... ssion, vaccination, and safety

@en

P2093

Moss B

http://www.w3.org/2001/XMLSchema#string

P2860

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene

Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase

Epitope mapping by deletion mutants and chimeras of two vesicular stomatitis virus glycoprotein genes expressed by a vaccinia virus vector.

High-voltage electron microscope study of the release of vaccinia virus from whole cells.

Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy

Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis

A poxvirus-derived vector that directs high levels of expression of cloned genes in mammalian cells.

Production of infectious human respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for va

Cytoplasmic expression system based on constitutive synthesis of bacteriophage T7 RNA polymerase in mammalian cells

P304

11341-11348

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.93.21.11341

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P577

1996-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14331032

http://www.w3.org/2001/XMLSchema#string

P698

8876137

http://www.w3.org/2001/XMLSchema#string

P932

38059

http://www.w3.org/2001/XMLSchema#string